# Seres Therapeutics, Inc.: Form DEF 14A, filed Mar 5, 2024

- Company: [Seres Therapeutics, Inc.](/companies/mcrb.md) (CIK 1609809)
- Form: DEF 14A
- Filed: 2024-03-05
- Accepted by EDGAR: Mar 5, 2024, 10:18 ET
- Period: 2024-03-05
- Accession: 0000950170-24-025482
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1609809/000095017024025482/mcrb-20240305.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1609809/000095017024025482/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1609809/000095017024025482/mcrb-20240305.htm

Filed Mar 5, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-025482. Last ingested by Listed: Oct 26, 2026, 16:31 ET. No prices; not investment advice.